10.1007/s12031-020-01508-9 24 LuoJ.ChenG.LiangM.XieA.LiQ.GuoQ.et al (2018)
On day 19 of admission, the infant, now generally in good condition with the metabolic acidosis corrected, was discharged
Incidences of dysesthesia occurred in 5.1%, 12.3%, and 12.5% of patients treated with retatrutide 4 mg, 9 mg, and 12 mg, respectively, compared with 0.9% with placebo, and incidences of urinary tract infections occurred in 7.5%, 8.8%, and 8.4% of patients treated with retatrutide 4 mg, 9 mg, and 12 mg, respectively, compared with 5.3% with placebo
She emphasizes that because GLP-1-related hair loss is primarily nutritional and systemic, serums should be viewed as a supportive measure, not a standalone fix
You can only feel it through reduced effectiveness
A proactive approach can make a meaningful difference, especially early in your treatment